Fronto-orbital intradiploic transitional meningioma.

1 US Food and Drug Administration. Topamax (topiramate) tablets prescribing information. Available from: http://www.fda.gov/medwatch/ SAFETY/2003/topamax.htm / http://www.fda.gov/medwatch/ SAFETY/2003/topamax.htm [last accessed on 2007 Mar 30]. 2 Angehagen M, Ben-Menachem E, Rönnbäck L, Hansson E. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine and topiramate. Neurochem Res 2000;28:333-40. 3 Sileberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group. Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 2004;61:490-5. 4 Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate in migraine prevention: A randomised controlled trial. JAMA 2004;291:965-73. 5 Limmroth V, Biondi D, Pfeil J, Schwalen S. Topiramte in patients with episodic migraine: Reducing the risk for chronic forms of headache. Headache 2007;47:13-21. 6 Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute bilateral secondary angle closure glaucoma. Ophthalmology 2004;111:109-11. 7 Langry HD, Gills JC, Davis R. Topiramate: A Review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997;54:752. 8 Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol 2001;132:112-4. 9 Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol 2001;119:1210-1. 10 Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol 2001;119:1721-3. 11 Ikeda N, Ikeda T, Nagata M, Mimura O. Ciliochoroidal effusion syndrome induced by sulfa derivatives. Arch Ophthalmol 2002;120:1775. Figure 1: Proposed sequence of events leading to retinal detachment[12,13] ciliochoroidal effusion